The psychopharmacology of European herbs with cognition-enhancing properties.

Human Cognitive Neuroscience Unit, Division of Psychology, Northumbria University, Newcastle upon Tyne, NE1 8ST UK.
Current pharmaceutical design (Impact Factor: 4.41). 02/2006; 12(35):4613-23. DOI: 10.2174/138161206779010387
Source: PubMed

ABSTRACT Extensive research suggests that a number of plant-derived chemicals and traditional Oriental herbal remedies possess cognition-enhancing properties. Widely used current treatments for dementia include extracts of Ginkgo biloba and several alkaloidal, and therefore toxic, plant-derived cholinergic agents. Several non-toxic, European herbal species have pan-cultural traditions as treatments for cognitive deficits, including those associated with ageing. To date they have not received research interest commensurate with their potential utility. Particularly promising candidate species include sage (Salvia lavandulaefolia/officinalis), Lemon balm (Melissa officinalis) and rosemary (Rosmarinus officinalis). In the case of sage, extracts possess anti-oxidant, estrogenic, and anti-inflammatory properties, and specifically inhibit butyryl- and acetyl-cholinesterase. Acute administration has also been found to reliably improve mnemonic performance in healthy young and elderly cohorts, whilst a chronic regime has been shown to attenuate cognitive declines in sufferers from Alzheimer's disease. In the case of Melissa officinalis, extracts have, most notably, been shown to bind directly to both nicotinic and muscarinic receptors in human brain tissue. This property has been shown to vary with extraction method and strain. Robust anxiolytic effects have also been demonstrated following acute administration to healthy humans, with mnemonic enhancement restricted to an extract with high cholinergic binding properties. Chronic regimes of aromatherapy and essential oil respectively have also been shown to reduce agitation and attenuate cognitive declines in sufferers from dementia. Given the side effect profile of prescribed cholinesterase inhibitors, and a current lack of a well tolerated nicotinic receptor agonist, these herbal treatments may well provide effective and well-tolerated treatments for dementia, either alone, in combination, or as an adjunct to conventional treatments.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Extracts of Melissa officinalis (Lemon Balm) are extensively used in traditional medicines. This study examined the anticonvulsant activity of the hydroalcoholic extract of M. officinalis on pentylenetetrazole (PTZ)-induced seizures threshold in mice. The fresh leaves and the whole plant of M. officinalis were used by a routine method to produce an injectable solution for administration. M. officinalis and normal Saline were injected intraperitoneally (IP) at the doses 100, 300, 600 and 900 and 1200 mg/kg, i.p and 10 ml/kg i.p, respectively, 30 min before the administration of PTZ (90 mg/kg, i.p). For measurement of anticonvulsant activity of animals, convulsive symptoms were divided into 3 level (scores 1-3) which were C 1 , C 2 and C 3 . The time taken before C 1 , C 2 and C 3 and the percentage of seizure and mortality protection rate were recorded. Statistical analyses of all treatment and control groups show that M. officinalis significantly can increases onset time of convulsive symptoms in all 3 levels of seizure in the PTZ model. On the other hand, onset time of convulsive symptoms increases by doses increasing which may indicate the dose-dependent effect of M. officinalis. It seems that it can be useful for treatment of seizure.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Lemon balm (Melissa officinalis) has been used historically and contemporarily as a modulator of mood and cognitive function, with anxiolytic effects following administration of capsules, coated tablets and topical application. Following a pilot study with lemon balm extract administered as a water based drink, which confirmed absorption of rosmarinic acid effects on mood and cognitive function, we conducted two similar double-blind, placebo-controlled, crossover studies. These evaluated the mood and cognitive effects of a standardised M. officinalis preparation administered in palatable forms in a beverage and in yoghurt. In each study a cohort of healthy young adults' self-rated aspects of mood were measured before and after a multi-tasking framework (MTF) administered one hour and three hours following one of four treatments. Both active lemon balm treatments were generally associated with improvements in mood and/or cognitive performance, though there were some behavioral "costs" at other doses and these effects depended to some degree on the delivery matrix.
    Nutrients 11/2014; 6(11):4805-4821. · 3.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Taxodione, a diterpenoid from the roots of Salvia chorassanica Bunge, possesses cytotoxic, apoptotic, and antimicrobial activity. This study was designed to investigate the protective effects of taxodione on serum/glucose deprivation-induced ischemic injury in PC12 cells and related mechanisms. In an in vitro model of ischemia, PC12 cells were exposed to serum and glucose deprivation for 6 and 18 h. The protective effects of the methanol extract of S. chorassanica and taxodione were assessed using alamarBlue(®) assay. Intracellular ROS production was measured by fluorimetry using 2',7'-dichlorofluorescin diacetate (DCFH-DA). The levels of PARP, Bcl-2, and Bax proteins were detected after western blot analysis. It was shown that taxodione (0.2-1.5 μM) significantly increased cell viability in a dose-dependent manner after ischemic insult. Taxodione has antioxidant activity and protects PC12 cells against oxidative stress-induced apoptotic cell death. Meanwhile, pretreatment with taxodione significantly induced an increase in Bcl-2 and a decrease in Bax protein level. The results of this study confirmed the protective effect of taxodione in serum/glucose deprivation-induced ischemic injury and the putative role of apoptosis as a underling mechanisms. Thus, it would be fair to consider taxodione as a promising ingredient of S. chorassanica for the expansion on novel class of anti-ischemic agents.
    Cellular and Molecular Neurobiology 09/2014; · 2.20 Impact Factor


Available from
May 20, 2014